ETFsXtrackers MSCI World Health Care UCITS ETF 1C
Xtrackers
Xtrackers MSCI World Health Care UCITS ETF 1C
XDWH LSEAccumulatingIreland
Last close · EUR
60.72EUR
+1.04% · +€0.62
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
XDWHBase
- Fund charges
- Not publishedFee basis unverified
- Fund size
- Not published
- Return 1Y
- +28.0%
- Sharpe 3Y
- 0.62
- Volatility 1Y
- 16.0%annualised
- Holdings
- 114Fund holdings
Performance
Compare
- XDWH+28.0%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| XDWH | +11.0% | +14.8% | +27.9% | +21.5% | +28.0% | +40.9% | +43.2% |
| MSCI World | +0.4% | +4.9% | +10.8% | +16.3% | +15.9% | +75.5% | +71.2% |
| Gap to MSCI World | +10.6% | +10.0% | +17.1% | +5.2% | +12.1% | -34.6% | -28.0% |
Risk and return
Sharpe ratio · 3Y
0.62
Below MSCI World · 1.24- Return p.a.
- +11.4%
- Volatility
- 14.7%
- Max loss
- -21.1%Aug 2025
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
XDWH
0.62
CAC 40
0.37
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 49.0%
- Holdings
- 114
- As of
- 1ELI LILLYUS532457108312.40%
- 2JOHNSON & JOHNSONUS47816010467.19%
- 3ABBVIEUS00287Y10915.70%
- 4UNITEDHEALTH GROUPUS91324P10214.04%
- 5MERCK & CO INCUS58933Y10554.04%
- 6ROCHE PS PAR AGCH14990599833.76%
- 7NOVARTIS AGCH00120052673.25%
- 8ASTRAZENECA PLCGB00098952923.09%
- 9THERMO FISHER SCIENTIFICUS88355610232.83%
- 10AMGEN INCUS03116210092.75%
Countries
Classified 100.0%
United States74.4%
CH
GB
JP
FR
DK
- Largest
- 74.4%United States
- Top 3
- 88.5%
- Effective number
- 1.81 / HHI
Market cap
Weight vs holdings
49.0%of the fund sits in the top 10 holdings
49.0%37.6%13.2%
WeightHoldings
104064
- Holdings 1-10
- Holdings 11-50
- Holdings 51-114
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.
